Initial GLP-1 Medication Evaluation

Service Description

Secure Telehealth Appointment 45–60 includes: Review of your medical and weight history Review of current medications and previous weight-loss treatments BMI, vital-sign and health-risk assessment Screening for contraindications and medication interactions Review or ordering of appropriate laboratory testing Discussion of FDA-approved weight-management medications Personalized medication and dose-escalation plan Prescription submission when clinically appropriate Injection-administration education Side-effect, nutrition and hydration counseling Pharmacy and insurance pathway guidance Best for: New clients seeking medication-focused medical weight management without enrolling in a monthly program. Your consultation includes: ✓ Comprehensive medical and weight-loss history ✓ Review of previous diets, medications, and weight-loss attempts ✓ Current medication and supplement review ✓ Medical and surgical history review ✓ Medication-safety and contraindication screening ✓ Blood pressure, weight, BMI, and waist-circumference assessment ✓ Advanced body-composition analysis ✓ Review of nutrition, physical activity, sleep, stress, and weight-loss barriers ✓ Review or ordering of clinically appropriate baseline laboratory testing ✓ Personalized weight-loss goals ✓ Discussion of medication options when clinically appropriate ✓ Individualized treatment plan and next-step recommendations Advanced body-composition analysis includes: • Skeletal Muscle Mass • Fat Mass • Body-Fat Percentage • Visceral Fat Best for: New clients who want a comprehensive medical assessment and a clear, personalized plan before beginning treatment. Please note: The consultation fee does not include prescription medications, laboratory testing, pharmacy charges, or enrollment in an ongoing weight-management program. Ingredients and concentrations may vary based on supplier availability, medical protocols, and individual patient needs. Your provider will review your treatment before administration.